Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2010, Article ID 595934, 7 pages
Review Article

Current Concepts on Antiplatelet Therapy: Focus on the Novel Thienopyridine and Non-Thienopyridine Agents

1Interventional Cardiology Department, St. Ambrogio Clinical Institute, 20149, Milan, Italy
2Institute of Cardiology, Ospedale “Le Molinette”, University of Turin, 10124, Turin, Italy
3Department of Cardiology, Arcispedale S. Anna, University of Ferrara, 44100, Ferrara, Italy
4Department of Cardiology, Royal North Shore Hospital, North Shore Heart Research Group, Kolling Institute, University of Sydney, Sydney NSW 2065, Australia

Received 23 March 2010; Accepted 16 August 2010

Academic Editor: David Varon

Copyright © 2010 L. Testa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [10 citations]

The following is the list of published articles that have cited the current article.

  • Alice M R Bernardino, Luiz C S Pinheiro, Edward R T Tiekink, James L Wardell, and Solange M S V Wardell, “N-(4-Chloro-phen-yl)-5-(4,5-dihydro-1H-imidazol-2-yl)thieno[2,3-b]pyridin-4-amine.,” Acta crystallographica. Section E, Structure reports online, vol. 68, no. Pt7, 2012. View at Publisher · View at Google Scholar
  • Kathleen A. Packard, Jennifer A. Campbell, Jon T. Knezevich, and Estella M. Davis, “Emerging Antiplatelet Therapy for Coronary Artery Disease and Acute Coronary Syndrome,” Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, vol. 32, no. 3, pp. 244–273, 2012. View at Publisher · View at Google Scholar
  • Peter Clemmensen, Nadia Paarup Dridi, and Lene Holmvang, “Dual Antiplatelet Therapy with Prasugrel or Ticagrelor Versus Clopidogrel in Interventional Cardiology,” Cardiovascular Drugs And Therapy, vol. 27, no. 3, pp. 239–245, 2013. View at Publisher · View at Google Scholar
  • Keith Eagen, Zhuyan Guo, Samuel Chackalamannil, Yan Xia, Hsingan Tsai, William J. Greenlee, Ho-Sam Ahn, Stan Kurowski, George Boykow, Yunsheng Hsieh, and Madhu Chintala, “Himbacine-Derived Thrombin Receptor Antagonists: C-7-Spirocyclic Analogues of Vorapaxar,” Acs Medicinal Chemistry Letters, vol. 5, no. 5, pp. 561–565, 2014. View at Publisher · View at Google Scholar
  • Lim Beng Leong, and Teng Kuan Peng David, “Is Platelet Transfusion Effective in Patients Taking Antiplatelet Agents Who Suffer an Intracranial Hemorrhage?,” The Journal of Emergency Medicine, 2015. View at Publisher · View at Google Scholar
  • Hardik Chandasana, Yashpal S. Chhonker, Yarra Durga Prasad, Tulsankar Sachin Laxman, K. S. Anil Kumar, Dinesh K. Dikshit, and Rabi S. Bhatta, “Pharmacokinetics and tissue distribution study of novel potent antiplatelet agent S007-867 in mice using HPLC-MS/MS,” Xenobiotica, pp. 1–8, 2015. View at Publisher · View at Google Scholar
  • Rafail Angelos Kotronias, Chun Shing Kwok, Chun Wai Wong, Tim Kinnaird, Azfar Zaman, and Mamas A. Mamas, “Cancer Event Rate and Mortality with Thienopyridines: A Systematic Review and Meta-Analysis,” Drug Safety, 2016. View at Publisher · View at Google Scholar
  • M Cavaco, and J Goncalves, “Interactions Between Therapeutic Proteins and Small Molecules: The Shared Role of Perpetrators and Victims,” Clinical Pharmacology & Therapeutics, 2017. View at Publisher · View at Google Scholar
  • Rodel V. Bobadilla, “Duration of Dual Antiplatelet Therapy in the Post–Acute Coronary Syndrome Patient,” The Journal of Cardiovascular Nursing, pp. 1, 2017. View at Publisher · View at Google Scholar
  • Cédric Garcia, Agnès Maurel-Ribes, Michel Nauze, Du N’Guyen, Laurent O. Martinez, Bernard Payrastre, Jean-Michel Sénard, Céline Galés, and Véronique Pons, “Deciphering biased inverse agonism of cangrelor and ticagrelor at P2Y12 receptor,” Cellular and Molecular Life Sciences, 2018. View at Publisher · View at Google Scholar